Third strand-mediated psoralen-induced correction of the sickle cell mutation on a plasmid transfected into COS-7 cells

Gene Ther. 2007 Jan;14(2):173-9. doi: 10.1038/sj.gt.3302850. Epub 2006 Aug 31.

Abstract

A significant level of correction of the mutation responsible for sickle cell anemia has been achieved in monkey COS-7 cells on a plasmid containing a beta-globin gene fragment. The plasmid was treated in vitro with a nucleic acid 'third strand' bearing a terminal photoreactive psoralen moiety that binds immediately adjacent to the mutant base pair. Following covalent attachment of the psoralen by monoadduct or diadduct formation to the mutant T-residue on the coding strand, the treated plasmid was transfected into the cells, which were then incubated for 48 h to allow the cellular DNA repair mechanisms to remove the photoadducts. Upon re-isolation and amplification of the transfected plasmid, sickle cell mutation correction, as determined by sequence analysis of both complementary strands, was established in a full 1%. This result encourages extension of the approach to correct the mutation directly on the chromosome.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / therapy*
  • Animals
  • COS Cells
  • Cell Line
  • Chlorocebus aethiops
  • DNA Adducts
  • DNA Repair
  • Furocoumarins / genetics*
  • Genetic Engineering
  • Genetic Therapy / methods*
  • Globins / genetics*
  • Humans
  • Plasmids / pharmacology*
  • Point Mutation
  • Transfection / methods*

Substances

  • DNA Adducts
  • Furocoumarins
  • Globins